Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients

J Clin Immunol. 2022 Feb;42(2):266-269. doi: 10.1007/s10875-021-01163-8. Epub 2021 Oct 31.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antibodies, Viral / immunology
  • COVID-19 / immunology
  • COVID-19 Vaccines / adverse effects*
  • COVID-19 Vaccines / immunology*
  • Female
  • Gain of Function Mutation / immunology*
  • Humans
  • Immunogenicity, Vaccine / immunology*
  • Male
  • Middle Aged
  • SARS-CoV-2 / immunology
  • STAT1 Transcription Factor / immunology*
  • Vaccines, Synthetic / adverse effects*
  • Vaccines, Synthetic / immunology*
  • mRNA Vaccines / adverse effects*
  • mRNA Vaccines / immunology*

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • Vaccines, Synthetic
  • mRNA Vaccine
  • mRNA Vaccines